Bimatoprost

Category: pharmacological

Aliases: Lumigan, Latisse

Pharmacological Mechanism

Prostamide F2α analog — same uveoscleral-outflow mechanism as latanoprost; topical formulation also FDA-approved for hypotrichosis (eyelash growth) as Latisse. Iris pigmentation change + periocular skin darkening.

Half-Life (t½)

TD: 1h

Dosing Guidelines

• TD: Typical 0.0003mg (Range: 0.0003 - 0.0003 mg)

Target Organ Systems

• integumentary